Greenwich LifeSciences Profit Margin

The latest profit margin for GLSI is -609342.05% as of June 2026. That compares with -498133.22% in the prior-year period — down 22.3% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Greenwich LifeSciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, GLSI's profit margin moved from -498133.22% to -609342.05% — a 22.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Greenwich LifeSciences's valuation or profitability profile.

Against Healthcare companies, GLSI currently prints -609342.05% for profit margin, while the sector average sits near 21.34%. That is roughly 2856140.2% below the sector mean. Large gaps often invite a closer look at Greenwich LifeSciences's growth, margins, and balance sheet.

Profit Margin shows how effectively Greenwich LifeSciences converts resources into returns. At -609342.05%, GLSI may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -498133.22% in the prior-year period — down 22.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting GLSI's profit margin (-609342.05%), review year-over-year change from -498133.22%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.